Robert Azelby Insider Trading $IMMU IMMUNOMEDICS INC
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Robert Azelby.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Robert Azelby. Robert Azelby is Director in IMMUNOMEDICS INC ($IMMU) and Director in Cascadian Therapeutics, Inc. ($CASC) and President and CEO in ALDER BIOPHARMACEUTICALS INC ($ALDR) and Director in Clovis Oncology, Inc. ($CLVS) and EVP & Chief Commercial Officer in Juno Therapeutics, Inc. ($JUNO) and See Remarks in Juno Therapeutics, Inc. ($JUNO).
Robert Azelby in IMMUNOMEDICS INC
Industry: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835]
Position of Robert Azelby: Director
Holdings: 3,718 shares
Current Value: $15,727
Latest Transaction: Jun 22 2020
$IMMU Market Capitalization: $442.84M
$IMMU Previous Close: $4.23
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of Robert Azelby in IMMUNOMEDICS INC
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, ALDR, CASC, CLVS, IMMU, JUNO
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jun 22 2020 | IMMU | IMMUNOMEDICS INC | Azelby Robert | Director | Option Exercise | A | 33.62 | 6,540 | 219,875 | 6,540 | |
| Jun 22 2020 | IMMU | IMMUNOMEDICS INC | Azelby Robert | Director | Grant | A | 0.00 | 3,718 | 0 | 3,718 | 0 to 3.7 K |
| Feb 27 2020 | IMMU | IMMUNOMEDICS INC | Azelby Robert | Director | Option Exercise | A | 16.36 | 22,500 | 368,100 | 22,500 |
Page: 1